Non Endometrioid Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non Endometrioid Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT05403554

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Study LCB-1801-001 is an open-label, Phase 1, dose escalation (Part A) and expansion (Part B), first-in-human clinical study of NI-1801 in patients with advance…

France, Italy70 participantsStarted 2022-04-29

Treatment: Biological NI-1801, NI-1801 in combination with anti-PD1 (Pembrolizumab)

All recent trials (15 shown)

Active — Not RecruitingPhase 2

NCT02834013

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…

United States818 participantsStarted 2017-01-30

Treatment: Biospecimen Collection, Computed Tomography

Active — Not RecruitingPhase 3

NCT02598219

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

The aim of this trial is to evaluate the sentinel node policy in early stage endometrial carcinomas at intermediate and high risk of recurrence (by comparing th…

France262 participantsStarted 2015-11

Treatment: Pre-operative SN mapping with radionucleide, Intra-operative SN mapping with patent V blue dye

Non Endometrioid Carcinoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

All recent trials (15 shown)

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

All recent trials (15 shown)

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

A Study to Investigate LYL797 in Adults With Solid Tumors

A Biomarker Screening Protocol for Participants With Solid Tumors

Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube C…

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Ca…

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer…

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cance…

Collecting Tumor Samples From Patients With Gynecological Tumors

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Gene Therapy in Treating Patients With Cancer